Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Negative Symptoms”

1,700 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,700 results

Not applicableStudy completedNCT04971057
What this trial is testing

Multimedia Information for Patients With Renal Biopsy

Who this might be right for
PainAnxietyHematuria
National Taipei University of Nursing and Health Sciences 100
Not applicableStudy completedNCT02884700
What this trial is testing

Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011.

Who this might be right for
Legionnaires' Disease
University Hospital, Grenoble 82
Not applicableStudy completedNCT03082807
What this trial is testing

Dietary Guide in Active Older Adult Men

Who this might be right for
MenDiet ModificationObesity+3 more
P.L.Shupik National Medical Academy of Post-Graduate Education 37
Large-scale testing (Phase 3)Ended earlyNCT00004465
What this trial is testing

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Who this might be right for
Hemolytic Uremic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 145
Not applicableUnknownNCT04208945
What this trial is testing

Nebulized Colistin for Gram Negative VAP Prevention.

Who this might be right for
Pneumonia, Ventilator-associatedGram-Negative Pneumonia
University of Thessaly 152
Testing effectiveness (Phase 2)Study completedNCT03092934
What this trial is testing

AK-01 (LY3295668) in Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisTriple Negative Breast Neoplasms+4 more
Eli Lilly and Company 13
Testing effectiveness (Phase 2)UnknownNCT04850664
What this trial is testing

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Who this might be right for
Opioid Use Disorder, ModerateOpioid Use Disorder, SevereWithdrawal Symptoms+2 more
Evon Medics LLC 190
Not applicableStudy completedNCT01891006
What this trial is testing

Intervention for Postpartum Infections Following Caesarean Section

Who this might be right for
Surgical Wound InfectionInfection; Cesarean SectionCesarean Section; Dehiscence+3 more
Odense University Hospital 26
Large-scale testing (Phase 3)Looking for participantsNCT07281833
What this trial is testing

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment

Who this might be right for
Breast CancerHR-positive Breast CancerAdvanced Breast Cancer+2 more
West German Study Group 250
Testing effectiveness (Phase 2)Ended earlyNCT04738292
What this trial is testing

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

Who this might be right for
ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
University of Wisconsin, Madison 11
Not applicableEnded earlyNCT03716687
What this trial is testing

Prophylactic Negative Pressure Wound Therapy for High Risk Laparotomy Wounds. A Randomized Prospective Clinical Trial.

Who this might be right for
Surgical WoundWound Dehiscence, SurgicalSurgical Site Infection+1 more
St. Borbala Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05438706
What this trial is testing

A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Fudan University 70
Large-scale testing (Phase 3)UnknownNCT02383030
What this trial is testing

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 156
Large-scale testing (Phase 3)Study completedNCT00174265
What this trial is testing

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)

Who this might be right for
Schizophrenia
Organon and Co 196
Not applicableStudy completedNCT07172932
What this trial is testing

ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

Who this might be right for
Bloodstream InfectionsEnterobacteriaceae InfectionsIntensive Care (ICU)+1 more
Ankara City Hospital Bilkent 314
Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65
Very early researchActive Not RecruitingNCT04674306
What this trial is testing

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Who this might be right for
Pathologic Stage IIA-IIIC Triple-Negative Breast CancerTNBC - Triple-Negative Breast CancerResidual Disease
George T. Budd 35
Post-approval studies (Phase 4)Looking for participantsNCT06401616
What this trial is testing

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

Who this might be right for
Atrial FibrillationLeft Atrial Appendage AbsentAnticoagulant Adverse Reaction
Odense University Hospital 1,220
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Large-scale testing (Phase 3)Study completedNCT00235352
What this trial is testing

Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia

Who this might be right for
Schizophrenia
North Suffolk Mental Health Association 105
Load More Results